Inventor · disambiguated record
Jae Young Ahn
Also filed as: AHN JAE YOUNG · AHN JAE YOUNG M
6 granted patents·9 pending applications·5 citations·filing 2016–2025
74Inventor score
Top patents by PatentIndex Score
15 records- 0195US11673902B2Isoindolinone and indazole compounds for the degradation of EGFRC4 THERAPEUTICS INC·Filed 2022·Granted Jun 13, 2023·3 cites·29 claims
- 0293US12371442B2Isoindolinone and indazole compounds for the degradation of EGFRC4 THERAPEUTICS INC·Filed 2023·Granted Jul 29, 2025·1 cites·28 claims
- 0380US12486290B2Isoindolinone and indazole compounds for the degradation of EGFRC4 THERAPEUTICS INC·Filed 2025·Granted Dec 2, 2025·0 cites·30 claims
- 0473US9994582B2Cortistatin analogues and syntheses and uses thereofHARVARD COLLEGE·Filed 2016·Granted Jun 12, 2018·1 cites·3 claims
- 0571US2024139185A1Compounds that participate in cooperative binding and uses thereofREVOLUTION MEDICINES INC·Filed 2023·Application pending·0 cites
- 0663US10508121B2Cortistatin analogues and syntheses and uses thereofHARVARD COLLEGE·Filed 2019·Granted Dec 17, 2019·0 cites·12 claims
- 0763US2024158418A1EGFR Degraders to Treat Cancer Metastasis to the Brain or CNSC4 THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0862US2020197391A1Compounds that participate in cooperative binding and uses thereofREVOLUTION MEDICINES INC·Filed 2019·Application pending·0 cites
- 0959US10273241B2Cortistatin analogues and syntheses and uses thereofHARVARD COLLEGE·Filed 2018·Granted Apr 30, 2019·0 cites·4 claims
- 1058US2025018046A1Compounds for targeting degradation of irak4 proteinsBIOGEN MA INC·Filed 2022·Application pending·0 cites
- 1156US2023233692A1Compounds for targeted degradation of retC4 THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1256US2024343733A1Compounds for targeting degradation of irak4 proteinsBIOGEN MA INC·Filed 2022·Application pending·0 cites
- 1356US2024287076A1Compounds for targeting degradation of bruton's tyrosine kinaseBIOGEN MA INC·Filed 2022·Application pending·0 cites
- 1446US2018369230A1Targeted selection of patients for treatment with specific cortistatin derivativesHARVARD COLLEGE·Filed 2018·Application pending·0 cites
- 1544US2019062340A1Cortistatin analogsHARVARD COLLEGE·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jae Young Ahn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →